日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Design, synthesis and antibacterial evaluation of piperazine urea-pyrazole-pyrimidine hybrids: in-vitro and in-silico studies

哌嗪脲-吡唑-嘧啶杂合物的设计、合成及抗菌活性评价:体外和计算机模拟研究

Choppadandi, Suresh; Vemula, Divya; Kerru, Nagaraju; Bhandari, Vasundhra; Srilakshmi, Chilukoti

Design and synthesis of isoxazole-functionalized benzene sulphonamides as novel inhibitors of Mycobacterium tuberculosis β-carbonic anhydrases

设计并合成异噁唑功能化的苯磺酰胺类化合物作为结核分枝杆菌β-碳酸酐酶的新型抑制剂

Bandela, Rani; Singampalli, Anuradha; Maddipatla, Sarvan; Kumar, Pardeep; Bellapukonda, Sri Mounika; Ramavath, Rajendhar; Mahajan, Lina S; Nanduri, Srinivas; Vemula, Divya; Dalal, Aman; Kalia, Nitin Pal; Bhandari, Vasundhra; Gratteri, Paola; Paoletti, Niccolò; Bonardi, Alessandro; Supuran, Claudiu T; Yaddanapudi, Venkata Madhavi

Proteome-wide identification of druggable targets and inhibitors for multidrug-resistant Pseudomonas aeruginosa using an integrative subtractive proteomics and virtual screening approach.

利用整合减法蛋白质组学和虚拟筛选方法,对多重耐药铜绿假单胞菌进行蛋白质组范围内的药物靶点和抑制剂鉴定

Vemula Divya, Bhandari Vasundhra

Sugar mimics and their probable binding sites: design and synthesis of thiazole linked coumarin-piperazine hybrids as galectin-1 inhibitors.

糖类类似物及其可能的结合位点:噻唑连接的香豆素-哌嗪杂合物作为半乳糖凝集素-1抑制剂的设计与合成

Sethi Aaftaab, Kumar Janish, Vemula Divya, Gadde Divya, Talla Venu, Qureshi Insaf A, Alvala Mallika

Repurposing of Food and Drug Admnistration (FDA) approved library to identify a potential inhibitor of trypanothione synthetase for developing an antileishmanial agent

利用美国食品药品监督管理局 (FDA) 批准的化合物库筛选锥虫硫合成酶的潜在抑制剂,以开发抗利什曼原虫药物。

Vemula, Divya; Mohanty, Shreelekha; Bhandari, Vasundhra

Homology modeling, virtual screening, molecular docking, and dynamics studies for discovering Staphylococcus epidermidis FtsZ inhibitors

利用同源建模、虚拟筛选、分子对接和动力学研究发现表皮葡萄球菌FtsZ抑制剂

Vemula, Divya; Maddi, Dhanashri Ramesh; Bhandari, Vasundhra